Skip to content
Screener

Total Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$267.95M-40.7%
ALN
Alnylam PharmaceuticalsALNY
$1.29B+66.9%
Assembly Biosciences logo
Assembly BiosciencesASMB
$8.21M-12.8%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$179.13M+10,055%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$214M+28.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$31.74M+325%

Other financials

Income statement

See full
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Six Months Ended March 31, 2026Six Months Ended March 31, 2025
Revenue$73,737$542,709$337,770$545,209
Operating expenses:
Research and development173,253133,102350,456270,104
Selling, general and administrative41,74428,40587,76555,315
Total operating expenses214,997161,507438,221325,419
Operating (loss) income(141,260)381,202(100,451)219,790
Other income (expense):
Interest income16,8699,61526,56017,217

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's total revenue?
Arrowhead Research (ARWR) reported total revenue of $73.74M in Q1 2026.
How has Arrowhead Research's total revenue changed year-over-year?
Arrowhead Research's total revenue decreased by 86.4% year-over-year, from $542.71M to $73.74M.
What is the long-term trend for Arrowhead Research's total revenue?
Over 4 years (2021 to 2025), Arrowhead Research's total revenue has grown at a 56.5% compound annual growth rate (CAGR), from $138.29M to $829.45M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Arrowhead Research's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude